Reimbursement and practice policies among providers of buprenorphine-naloxone treatment
- PMID: 23577902
- DOI: 10.1080/08897077.2012.677753
Reimbursement and practice policies among providers of buprenorphine-naloxone treatment
Abstract
ABSTRACT Background: Physician acceptance of cash payment and low adherence to practice guidelines may contribute to buprenorphine-naloxone diversion. The purpose of this study was to investigate the clinical practice policies of physicians who provide office-based treatment for opioid dependence with buprenorphine-naloxone.
Methods: Data were obtained from 31 of 71 practices surveyed (response rate 43.7%) that provided answers to at least some of the survey questions.
Results: Of these practices, 28 (90.3%) accepted cash as payment and 6 (19.4%) accepted only cash for treatment services. Analysis of open-ended responses to questions about office policies revealed wide variation among practices and overall suboptimal adherence to recommended treatment guidelines.
Conclusions: These results underscore the need for continuing education for physicians who prescribe buprenorphine-naloxone.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
